Multiple sclerosis trials in India

1 of 1 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  Where

  Chandigarh, Gurugram, Hyderabad, Kochi, Mangalore, New Delhi, Vellore

  Age

  18 years to 65 years

  People

  1,275 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07225504